Publicação
Pfizer equity report
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | André, Rosário | |
| dc.contributor.author | Sampaio, Pedro Maria Faria de Carvalho Corrêa de | |
| dc.date.accessioned | 2022-11-09T12:07:25Z | |
| dc.date.available | 2022-11-09T12:07:25Z | |
| dc.date.issued | 2022-06-17 | |
| dc.date.submitted | 2021-12-17 | |
| dc.description.abstract | The goal of thi spaper was to find the intrinsic value of Pfizer($PFE).In order to achieve this, an analysis was made of its business units and the Pharmaceutical Industry as a whole. Our valuation model, based on forecasted values, got us a share price of $69.28, which allows us to understand how fundamentally undepreciated is the current stock price. | pt_PT |
| dc.identifier.tid | 203082893 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/145347 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | Nova School of Business and Economics | |
| dc.subject | Valuation | pt_PT |
| dc.subject | Finance | pt_PT |
| dc.title | Pfizer equity report | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| oaire.awardNumber | UID/ECO/00124/2013 | |
| oaire.awardTitle | Nova School of Business and Economics | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FECO%2F00124%2F2013/PT | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| relation.isProjectOfPublication | 644a3f4f-817b-4d0d-aba6-f98cdca28bc7 | |
| relation.isProjectOfPublication.latestForDiscovery | 644a3f4f-817b-4d0d-aba6-f98cdca28bc7 | |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics | pt_PT |